Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05828940Completed
Randomised, double-blind trial in post-traumatic stress disorder (PTSD) and anxiety disorders comparing Losartan 50mg with Placebo (2 arms). Primary endpoint: BOLD activation in hippocampus during new>familiar contrast. Started Oct 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05828940.